Alternative Approach for Right Ventricular Failure after Left Ventricular Assist Device Placement in Animal Model
Alternative Approach for Right Ventricular Failure after Left Ventricular Assist Device Placement in Animal Model
复制标题
动物模型中左心室辅助装置放置后右心室衰竭的替代方法
DOI:
10.1093/ejcts/ezu364
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Yoshiyuki Taenaka and Eisuke Tatsumi
中科院分区:
文献类型:
--
作者:
Tomohiro Saito;Koichi Toda;Yoshiaki Takewa;Tomonori Tsukiya;Toshihide Mizuno;Yoshiyuki Taenaka and Eisuke Tatsumi
OBJECTIVESRight ventricular failure after left ventricular assist device (LVAD) implantation is associated with high mortality. This study was designed to evaluate the effectiveness of an atrial septostomy with a membrane oxygenator incorporated in an LVAD as a novel approach for right ventricular failure after LVAD implantation.METHODSThe outflow and inflow cannulae were placed in the carotid artery and left ventricular apex, respectively. A centrifugal pump and an oxygenator were sequentially placed between the inflow and outflow cannulae in seven anesthetized goats. While right ventricular failure was induced by pulmonary artery banding, a balloon atrial septostomy was performed using a 19-mm balloon catheter under echocardiographic guidance. We investigated the effects of the interatrial shunt on LVAD flow and haemodynamics.RESULTSDevelopment of right ventricular failure decreased LVAD flow (2.7 ± 0.6–0.9 ± 0.6 l/min), causing a state of shock [mean arterial pressure (MAP) of 41 ± 12 mmHg]. Following a balloon atrial septostomy, LVAD flow and MAP were significantly improved to 2.7 ± 0.4 l/min (P< 0.001) and 53 ± 18 mmHg (P= 0.006), respectively, while right atrial pressure decreased from 18 ± 5 to 15 ± 5 mmHg (P= 0.001). Furthermore, arterial blood oxygenation was maintained by the membrane oxygenator incorporated in the LVAD.CONCLUSIONSIn the present model of right ventricular failure after LVAD implantation, LVAD flow was significantly increased and haemodynamics improved without compromising systemic oxygenation by the use of an interatrial shunt and a membrane oxygenator incorporated in the LVAD. Our results indicate that this novel approach may be less invasive for a right ventricular failure after LVAD implantation.